Results 121 to 130 of about 6,898 (170)
Some of the next articles are maybe not open access.

Immunogenicity of Amodiaquine in the Rat

International Archives of Allergy and Applied Immunology, 2009
Amodiaquine is an antimalarial drug that has been associated with adverse reactions which may be immune mediated. Specific IgG anti-amodiaquine antibodies were detected after administration of the drug to rats (269 μmol/kg for 4 days), using an enzyme-linked immunosorbent assay employing amodiaquine conjugated to metallothionein as an antigen.
J B, Clarke   +3 more
openaire   +2 more sources

Amodiaquine Ocular Changes

Archives of Ophthalmology, 1982
A 34-year-old man ingested more then 250 g of amodiaquine hydrochloride (for pain) during one year and was noted to have diffuse conjunctival, corneal, and skin changes and also abnormal results from retinal function tests. Ultrastructural examination of corneal and conjunctival biopsy specimens revealed intralysosomal membranous and amorphous ...
L W, Hirst   +4 more
openaire   +2 more sources

Amodiaquine as a prodrug: Importance of metabolite(s) in the antimalarial effect of amodiaquine in humans

Life Sciences, 1985
Existing analytical methods for assaying the 4-aminoquinoline antimalarial amodiaquine in body fluids are nonspecific and obscure the fact that little or no amodiaquine is present in the blood of dosed persons. We have isolated four metabolites of amodiaquine. The two major metabolites have been identified; one is desethylamodiaquine, and the other has
F C, Churchill   +5 more
openaire   +2 more sources

Amodiaquine

Reactions Weekly, 2010
Thomas Schulz   +2 more
openaire   +2 more sources

Amodiaquine

The Lancet, 1996
Peter B Bloland, Trenton K Ruebush
openaire   +1 more source

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia

Clinical Infectious Diseases, 2021
Melissa Mairet-Khedim   +2 more
exaly  

[Tolerance of amodiaquine].

Medecine tropicale : revue du Corps de sante colonial, 2008
Amodiaquin is still considered as a poorly tolerated antimalarial causing hematological and hepatic toxicity. In view of complications observed during prophylaxis, the WHO has advised against the use of amodiaquin for prophylaxis as well as treatment.
openaire   +1 more source

AMODIAQUINE

The Lancet, 1961
openaire   +1 more source

Home - About - Disclaimer - Privacy